Legend Biotech Corp (LEGN) Shareholders’ equity 2019–2024
Legend Biotech Corp (LEGN) shareholders’ equity at each fiscal year-end, per SEC filings.
$1.0BFY2024 · since FY2019: -$122.9M → $1.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $1.0B | -16.8% |
| FY2023 | $1.3B | +68.1% |
| FY2022 | $744.3M | -2.8% |
| FY2021 | $765.9M | +28.1% |
| FY2020 | $597.8M | +586.5% |
| FY2019 | -$122.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice